3 Stocks To Transform Your Portfolio: HSBC Holdings plc, GlaxoSmithKline plc And Banco Santander SA

HSBC Holdings plc (LON: HSBA), GlaxoSmithKline plc (LON: GSK) and Banco Santander SA (LON: BNC) could make all the difference to your finances

| More on:

The content of this article was relevant at the time of publishing. Circumstances change continuously and caution should therefore be exercised when relying upon any content contained within this article.

When investing, your capital is at risk. The value of your investments can go down as well as up and you may get back less than you put in.

Read More

The content of this article is provided for information purposes only and is not intended to be, nor does it constitute, any form of personal advice. Investments in a currency other than sterling are exposed to currency exchange risk. Currency exchange rates are constantly changing, which may affect the value of the investment in sterling terms. You could lose money in sterling even if the stock price rises in the currency of origin. Stocks listed on overseas exchanges may be subject to additional dealing and exchange rate charges, and may have other tax implications, and may not provide the same, or any, regulatory protection as in the UK.

You’re reading a free article with opinions that may differ from The Motley Fool’s Premium Investing Services. Become a Motley Fool member today to get instant access to our top analyst recommendations, in-depth research, investing resources, and more. Learn More.

Cash

Sometimes, it’s difficult to find high-quality companies trading at attractive valuations. Indeed, during bull markets it can be especially tough, as valuations become rather excessive.

However, with the FTSE 100 still being at roughly the same price level as it was fourteen years ago, there seems to be a number of high-quality companies trading at low prices. Here are three examples that could transform your portfolio returns over the medium term.

HSBC

With a large exposure to Asia, HSBC (LSE: HSBA) (NYSE: HSBC.US) seems to be well positioned to benefit from an economic tailwind. That’s because demand for new loans should increase as the Asian economy develops towards a more consumer-based model over the long run.

However, even in the short run, HSBC has huge potential. For example, it is expected to increase earnings per share (EPS) by 6% in the current year and by 7% next year. This rate of growth may not be quite as impressive as some of its UK-listed banking peers but, when you consider that HSBC has remained profitable throughout the credit crunch, steady, resilient earnings start to become much more attractive.

With shares in HSBC trading on a price to earnings (P/E) ratio of just 12.1, they seem to offer good value as well as upbeat growth prospects.

GlaxoSmithKline

Although sentiment surrounding GlaxoSmithKline (LSE: GSK) (NYSE: GSK.US) remains weak due to allegations of bribery, the long term still looks very bright for the pharmaceutical major. That’s because its pipeline of drugs is well diversified and has huge potential when it comes to gaining approval for key, blockbuster drugs.

Despite these strong prospects, shares in GlaxoSmithKline still offer great value right now. For example, they trade on a P/E of 15.2. While this is above the FTSE 100’s rating of 13.6, it’s well below many of its pharmaceutical peers, where P/Es of 20+ are commonplace.

Allied to great value is a top notch yield of 5.6%, which makes GlaxoSmithKline a strong income as well as value (and growth) play.

Santander

When it comes to growth potential, Santander (LSE: BNC) has it in bucket loads. For example, earnings are forecast to increase by 23% in the current year and by a further 22% next year. This is a stunning rate of growth and means that, with shares in Santander trading on a P/E ratio of 15.8, the bank offers growth at a reasonable price via a price to earnings growth (PEG) ratio of 0.6.

Furthermore, Santander yields 6.5% and, as of next year, dividends per share are expected to be covered by profit. This puts Santander on a much stronger financial footing moving forward and means that its shares could boost your portfolio returns.

Should you invest, the value of your investment may rise or fall and your capital is at risk. Before investing, your individual circumstances should be assessed. Consider taking independent financial advice.

Peter Stephens owns shares of GlaxoSmithKline and HSBC Holdings. The Motley Fool UK has recommended GlaxoSmithKline. We Fools don't all hold the same opinions, but we all believe that considering a diverse range of insights makes us better investors.

More on Investing Articles

Google office headquarters
Investing Articles

1 reason I like buying S&P 500 shares – and 1 reason I don’t

Will this investor try to improve his potential returns by focusing more on S&P 500 shares instead of British ones?…

Read more »

Young woman holding up three fingers
Investing Articles

3 SIPP mistakes to avoid

Our writer explains a trio of potentially costly errors he tries to avoid making when investing his SIPP, on an…

Read more »

Smiling white woman holding iPhone with Airpods in ear
Investing Articles

Here’s how (and why) I’d start buying shares with £25 a week

Our writer uses his investment experience and current approach to explain how he would start buying shares on a limited…

Read more »

Aerial shot showing an aircraft shadow flying over an idyllic beach
Investing Articles

Here’s my 5-step approach to earning passive income of £500 a month

Christopher Ruane explains the handful of steps he uses to target hundreds of pounds in passive income each month.

Read more »

Investing Articles

2 UK shares I’ve been buying this week

From a value perspective, UK shares look attractive. But two in particular have been attracting Stephen Wright’s attention over the…

Read more »

Investing Articles

A lifelong second income for just £10 a week? Here’s how!

With a simple, structured approach to buying blue-chip dividend shares at attractive prices, our writer's building a second income for…

Read more »

Investing Articles

Here’s how I’d use a £20k Stocks and Shares ISA to help build generational wealth

Discover how our writer would aim to turn a £20k Stocks and Shares ISA into a sizeable nest egg by…

Read more »

Investing Articles

Billionaire Warren Buffett just bought shares of Domino’s Pizza. Should I grab a slice?

Our writer takes a look at a few reasons why Domino's Pizza stock might have appealed to Warren Buffett's Berkshire…

Read more »